Effects of nicotinic acid and lovastatin in combination with cholestyramine in renal transplant patients
Lal, S.M.; Katyal, A.
Missouri Medicine 99(10): 580-584
2002
ISSN/ISBN: 0026-6620 PMID: 12534147 Document Number: 544967
We assessed the short and long-term efficacy and safety of the lipid lowering drugs, nicotinic acid, and the HMG-CoA reductase inhibitor, lovastatin, in combination with cholestyramine in four renal transplant patients. Combination therapy with cholestyramine failed to lower the TC and LDL to the levels recommended by the NCEP guidelines.
Document emailed within 1 workday
Related Documents
Kliem, V.; Wanner, C.; Eisenhauer, T.; Olbricht, C.J.; Doll, R.; Boddaert, M.; O'Grady, P.; Krekler, M.; Mangold, B.; Christians, U. 1996: Comparison of pravastatin and lovastatin in renal transplant patients receiving cyclosporine Transplantation Proceedings 28(6): 3126-3128Santanu, G.; Suhrita, P.; Mookerjee, S.; Tania, K.; Mita, S.; Pramit, G.; Sharmila, G.; Miraj, M.; Debdutta, M. 2011: Lipid modifying action of atorvastatin in comparison to combination of atorvastatin and nicotinic acid in patients with ischaemic heart disease Indian Heart Journal 63(5): 434-437
Lumlertgul, D.; Noppakun, K.; Rojanasthien, N.; Kanchanarattanakorn, K.; Jittikanont, S.; Manoyot, A.; Bunnachak, D.; Ophascharoensuk, V. 2006: Pharmacokinetic study of the combination of tacrolimus and fluconazole in renal transplant patients Journal of the Medical Association of Thailand 89(Suppl 2): S73-S78
Imai, T.; Suzuki, S. 1971: Pyridine nucleotides. II. Isolation and identification of alpha-isomers of nicotinic acid mononucleotide and nicotinic acid-adenine dinucleotide Seikagaku. Journal of Japanese Biochemical Society 43(6): 346-362
Ivanovski, N.; Stojceva-Taneva, O.; Grozdanovski, R.; Boskovska, M.; Drueke, T.B.; Massy, Z.A. 2004: Short-term effect of folic acid supplementation in renal transplant recipients and chronic kidney disease patients with comparable renal function impairment Nephrologie 25(7): 301-303
Idzior-Waluś, B. 1992: Influence of lovastatin on serum lipids in patients with primary hyperlipidemia and phenotype IIa and IIB. II. Changes of lipid composition of plasma lipoprotein fractions after lovastatin administration Przeglad Lekarski 49(10): 327-333
Debnath, S.C.; Abomelha, M.S.; Jawdat, M.; Chang, R.; Al-Khader, A.A. 1987: Ocular side effects of systemic steroid therapy in renal transplant patients Annals of Ophthalmology 19(11): 435-437
Pabico, R.C.; McKenna, B.A. 1988: Metabolic problems in renal transplant patients. Persistent hyperparathyroidism and hypophosphatemia: effects of intravenous calcium infusion Transplantation Proceedings 20(1 Suppl 1: 438-442
Senel, M.F.; Van Buren, C.T.; Etheridge, W.B.; Barcenas, C.; Jammal, C.; Kahan, B.D. 1996: Effects of cyclosporine, azathioprine and prednisone on Kimura's disease and focal segmental glomerulosclerosis in renal transplant patients Clinical Nephrology 45(1): 18-21
Kaijser, L.; Eklund, B.; Olsson, A.G.; Carlson, L.A. 1979: Dissociation of the effects of nicotinic acid on vasodilatation and lipolysis by a prostaglandin synthesis inhibitor, indomethacin, in man Medical Biology 57(2): 114-117
Vitolo, E.; Segalini, G.; Carini, L.; Castini, D.; Moreo, A.; Mazzola, C.; Segagni, S.; Villa, G.; Salvadeo, A. 1988: Effects of ibopamine in combination with furosemide on renal function in patients with chronic congestive heart failure International Journal of Clinical Pharmacology Therapy and Toxicology 26(7): 327-334
Forti, N.; Ramires, J.A. 1991: Effects of lovastatin and probucol on lipoprotein fractions in patients with hypercholesterolemia. a Brazilian multicenter study Arquivos Brasileiros de Cardiologia 57(3): 253-261
Santagostino, A.; Pagani, G.; Ballerio, G.; Porro, T. 1979: Metabolic changes induced by a nicotinic acid derivative in patients with obesity grades 1, 2 and 3 Panminerva Medica 21(3): 111-126
Homan van der Heide, J.J.; Bilo, H.J.; Donker, A.J.; Wilmink, J.M.; Sluiter, W.J.; Tegzess, A.M. 1992: The effects of dietary supplementation with fish oil on renal function and the course of early postoperative rejection episodes in cyclosporine-treated renal transplant recipients Transplantation 54(2): 257-263
Zuliani, U.; Bonetti, A.; Orlandini, G.; Manari, A.; David, S.; Garini, G. 1981: Pharmacokinetics and antilipolytic effect of a derivative of nicotinic acid (sorbinicate) in dialyzed uremic patients Il Farmaco; Edizione Pratica 36(9): 416-423
Varnakova, G.M. 1983: Use of nicotinamide for correcting the disordered nicotinic acid allowance of patients with noncoronarogenic heart diseases Voprosy Pitaniia 4: 32-35
Curtis, L.D.; Dickson, A.C.; Ling, K.L.; Betteridge, J. 1988: Combination treatment with cholestyramine and bezafibrate for heterozygous familial hypercholesterolaemia Bmj 297(6642): 173-175
Belukha, U.K.; Rumi, T.K.; Luk'ianova, A.S.; Rynkova, T.V.; Shopina, M.F. 1978: Effect of griseofulvin/on the riboflavin and nicotinic acid content in patients with tinea pedis caused by Trichophyton rubrum Vestnik Dermatologii i Venerologii 1978(11): 24-28
Aufy, S.M.; Mahgoub, A.M.A.; Saadi, M.G.E.-D.; Adel Elmallawany, M. 2009: Serological detection of Toxoplasma gondii in chronic renal failure patients and renal transplant recipients Journal of the Egyptian Society of Parasitology 39(3): 943-950
Sadek, S.; Medina, Jé.; Arias, M.; Sennesael, J.; Squifflet, J-Paul.; Vogt, B. 2002: Short-term combination of mycophenolate mofetil with cyclosporine as a therapeutic option for renal transplant recipients: A prospective, multicenter, randomized study Transplantation 74(4): 511-517